https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-06-20 / J. Hepatol. 2005 Nov;43(5):817-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-06-20 / J. Hepatol. 2005 Nov;43(5):817-222005-06-20 00:00:002019-02-15 09:11:51Activation of dendritic cells by local ablation of hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-06-01 / Zhonghua Gan Zang Bing Za Zhi 2005 Jun;13(6):432-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-06-01 / Zhonghua Gan Zang Bing Za Zhi 2005 Jun;13(6):432-52005-06-01 00:00:002019-02-15 09:04:05[Clinical effects of dendritic cells pulsed with autologous hepatoma cell lysates on the postoperative recurrence and metastasis of hepatocellular carcinoma]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-05-01 / Int. J. Oncol. 2005 May;26(5):1313-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-05-01 / Int. J. Oncol. 2005 May;26(5):1313-92005-05-01 00:00:002019-02-15 09:03:14Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-12-01 / J. Hepatol. 2004 Dec;41(6):999-1007
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-12-01 / J. Hepatol. 2004 Dec;41(6):999-10072004-12-01 00:00:002019-02-15 09:11:52Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-11-01 / Eur J Gastroenterol Hepatol 2004 Nov;16(12):1257-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-11-01 / Eur J Gastroenterol Hepatol 2004 Nov;16(12):1257-602004-11-01 00:00:002019-02-15 09:11:53The role of the immune system in the control of hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-11-01 / Gastroenterology 2004 Nov;127(5 Suppl 1):S232-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-11-01 / Gastroenterology 2004 Nov;127(5 Suppl 1):S232-412004-11-01 00:00:002019-02-15 09:13:24Immunotherapeutic strategies for hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-11-01 / Z Gastroenterol 2003 Nov;41(11):1101-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-11-01 / Z Gastroenterol 2003 Nov;41(11):1101-102003-11-01 00:00:002019-02-15 09:13:25Immunobiology and gene-based immunotherapy of hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-06-01 / Int. J. Oncol. 2003 Jun;22(6):1397-402
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-06-01 / Int. J. Oncol. 2003 Jun;22(6):1397-4022003-06-01 00:00:002019-02-15 09:13:26Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-02-06 / Cancer Immunol. Immunother. 2003 Mar;52(3):155-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-02-06 / Cancer Immunol. Immunother. 2003 Mar;52(3):155-612003-02-06 00:00:002019-02-15 09:13:27A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-11-01 / Hepatology 2001 Nov;34(5):896-905
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-11-01 / Hepatology 2001 Nov;34(5):896-9052001-11-01 00:00:002019-02-15 09:13:28Effective treatment of small murine hepatocellular carcinoma by dendritic cells
